WHO ICTRP trial

Ophthalmological and Dermatological Safety Study to Determine Possible Benefits…

CTRI/2013/10/004093 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2013/10/004093
Public title Ophthalmological and Dermatological Safety Study to Determine Possible Benefits of Dheedhi Herbal Kajal.
Scientific title An Open Label, Prospective, Non-comparative, Single Arm Study to Evaluate the Ophthalmological and Dermatological Safety and Possible Benefits of Dheedhi Herbal Kajal in Clinically Healthy Female Adults.
Primary sponsor Dhathri Ayurveda Private Limited
Secondary sponsors Aurous HealthCare Research and Development India Private Limited
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 4
Countries India
Interventions Intervention1: Dheedhi Herbal Kajal: Kajal (eyeliner) containing 12 herbal extracts. The Kajal is to be applied on the upper and lower lashline twice a day - morning and evening. The total duration of usage is 4 weeks. Control…
Registration date Oct 23, 2013
Target size 24
Secondary IDs AHC/DEROPH/021/13
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations